Uptake of new antidiabetic medicines in 11 European countries

Uptake of new antidiabetic medicines in 11 European countries

Abstract Background Several new antidiabetic medicines (GLP-1 receptor agonists, DPP-4 inhibitors, and SGLT-2 inhibitors) have been approved by the European Medicines Agency since 2006. The aim of this study was to evaluate the uptake of new antidiabetic medicines in European countries over a 10-yea...

Full description

Bibliographic Details
Main Authors: Nika Mardetko, Urska Nabergoj Makovec, Igor Locatelli, Andrej Janez, Mitja Kos
Format: Article
Language:English
Published: BMC 2021-06-01
Series:BMC Endocrine Disorders
Subjects:
Diabetes Mellitus
Glucagon-Like Peptide 1 receptor agonists
Dipeptidyl-Peptidase 4 inhibitors
Sodium-Glucose Transporter 2 inhibitors
Insulins
Market uptake
Online Access:https://doi.org/10.1186/s12902-021-00798-3

Internet

https://doi.org/10.1186/s12902-021-00798-3

Similar Items